Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-08-27), Link Pharma Chem's 9-Day RSI is 59.81.
The industry rank for Link Pharma Chem's 9-Day RSI or its related term are showing as below:
BOM:524748's 9-Day RSI is ranked worse than 73.16% of 1654
companies
in the Chemicals industry
Industry Median: 51.655
vs BOM:524748: 59.81
Link Pharma Chem (BOM:524748) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Link Pharma Chem 9-Day RSI Related Terms
BOM:524748 vs DOW: 9-Day RSI Comparison
For the Chemicals subindustry, Link Pharma Chem's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Link Pharma Chem 9-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Link Pharma Chem's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Link Pharma Chem's 9-Day RSI falls into.
Link Pharma Chem (BOM:524748) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Link Pharma Chem (BOM:524748) has a 9-Day RSI of 59.81 as of Aug. 27, 2026. According to the industry distribution chart, Link Pharma Chem ranks #1210 out of 1654 companies in the Chemicals industry, placing it in the top 73.2%.
Is Link Pharma Chem's 9-Day RSI too high?
Link Pharma Chem's current 9-Day RSI is 59.81. The Chemicals industry median 9-Day RSI is 51.66. Link Pharma Chem's value of 59.81 is 15.8% above this industry median. Based on the distribution chart, Link Pharma Chem ranks #1210 out of 1654 companies in the Chemicals industry, which is below the industry midpoint. Overall, Link Pharma Chem has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Link Pharma Chem's 9-Day RSI compare to DOW?
According to the Chemicals industry distribution chart, Link Pharma Chem ranks #1210 out of 1654 companies for 9-Day RSI. This places Link Pharma Chem in the lower half of its industry. The industry median 9-Day RSI is 51.66. Link Pharma Chem's value of 59.81 is 15.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Chemicals company?
The median 9-Day RSI among Chemicals companies is 51.66, based on 1,654 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Link Pharma Chem's current 9-Day RSI of 59.81 is 15.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median 9-Day RSI is 51.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Link Pharma Chem's current 9-Day RSI is 59.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Link Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Link Pharma Chem (BOM:524748) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹36.75, compared to a current price of ₹28.00 — trading 23.8% below its estimated fair value. The current 9-Day RSI is 59.81 and 15.8% above the Chemicals industry median of 51.66. Link Pharma Chem's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Link Pharma Chem (BOM:524748), the current 9-Day RSI is 59.81 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Link Pharma Chem (BOM:524748) Overvalued in 2026?
Based on GuruFocus' analysis, Link Pharma Chem stock appears to be undervalued.
The current stock price of ₹28.00 is trading 23.8% below its estimated GF Value™ of ₹36.75.
GuruFocus considers Link Pharma Chem to be Modestly Undervalued.
Key valuation signals for BOM:524748:
9-Day RSI: 59.81
GF Value™: ₹36.75 vs. price of ₹28.00 (23.8% below fair value)
Industry Position: 15.8% above the Chemicals median (#1210 of 1654)
No single metric tells the full story. See the BOM:524748 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Link Pharma Chem Ltd is engaged in the manufacturing and selling of organic intermediates which are used in pharmaceuticals, agro and speciality chemical industries. The company has its manufacturing location at Nandesari in Gujarat. It operates through single segment which is Chemical manufacturing and generates revenue from the same. The company generates the majority of its revenue from domestic sales.
61GF Score
Get the complete analysis for BOM:524748
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524748 has been successfully added to your 
